SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001267602-23-000125
Filing Date
2023-11-02
Accepted
2023-11-01 20:03:15
Documents
77
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alim-20230930x10q.htm   iXBRL 10-Q 4536207
2 EX-31.1 alim-20230930xex31_1.htm EX-31.1 20942
3 EX-31.2 alim-20230930xex31_2.htm EX-31.2 21116
4 EX-32.1 alim-20230930xex32_1.htm EX-32.1 15909
  Complete submission text file 0001267602-23-000125.txt   15317517

Data Files

Seq Description Document Type Size
5 EX-101.SCH alim-20230930.xsd EX-101.SCH 58603
6 EX-101.CAL alim-20230930_cal.xml EX-101.CAL 69386
7 EX-101.DEF alim-20230930_def.xml EX-101.DEF 225299
8 EX-101.LAB alim-20230930_lab.xml EX-101.LAB 568200
9 EX-101.PRE alim-20230930_pre.xml EX-101.PRE 428323
71 EXTRACTED XBRL INSTANCE DOCUMENT alim-20230930x10q_htm.xml XML 3628595
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34703 | Film No.: 231369658
SIC: 2834 Pharmaceutical Preparations